Christopher D. Roberts, Chief Scientific Officer at Black Diamond Therapeutics, Inc. (BDTX), sold 4,463 shares at $31.31 ($140K) on 2021-01-04, disclosed to the SEC on 2021-01-06.
Open-market sale of $140k BDTX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $31.31 | 1,963 | $61K | 43.9% |
| 2 | $31.31 | 1,963 | $61K | 43.9% |
| 3 | $31.78 | 537 | $17K | 12.2% |
| Total | $31.37 avg | 4,463 | $140K | 100% |
| Filing → |
| BDTX | SELL | 2021-03-04 | $65K | — | Filing → |
| BDTX | SELL | 2021-02-04 | $63K | — | Filing → |
| BDTX | SELL | 2020-12-04 | $81K | — | Filing → |